We measured the supernatant of RA-FLS by ELISA and found that CAY10603 downregulated the secretion of TNF-α and IL-6 inflammatory factors in RA-FLS, further suggesting that CAY10603 could delay the onset of RA, which was consistent with the expected results. Here, IL6 is linked to rheumatoid arthritis.